Antibody, Biobanking and Genetics - Clinical Research Informer

Can genetic data be a magic bullet for drug R&D?

pharmaphorum

JANUARY 24, 2023

Ben Hargreaves finds that the vast amount of genetic data that exists today could help provide a faster, more targeted way of developing new drug candidates. The logical extension to this kind of approach is treating individual patients, with their individual genetic makeup.

Genetics

Genetics Drugs Genome Project Biobanking

Research Roundup: Blood Test for Severe COVID-19 and More

The Pharma Data

JANUARY 21, 2021

Doctors need better tools to evaluate the status of COVID-19 patients as early as possible because many of the treatments—such as monoclonal antibodies—are in short supply, and we know that some patients will get better without intensive treatments,” said co-senior author Andrew E. The research was published in the journal JCI Insight.

Research

Research DNA Hormones Vaccine

Clinical Research Informer

Can genetic data be a magic bullet for drug R&D?

Research Roundup: Blood Test for Severe COVID-19 and More

Webinars

Stay Connected